Found 9 matching trials
Study of NM8074 in Adult C3 Glomerulopathy Patients
PHASE1This is a Phase Ib, open-label, dose-escalation study designed to evaluate ...
Location
Multiple Locations
Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
PHASE2The proposed study, NM8074-PNH-101, is a phase II, open-label, multi-dose, ...
Location
Multiple Locations
Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy
PHASE2This is a Phase II, open-label study designed to evaluate the safety, effic...
Location
Multiple Locations
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
PHASE2This is a Randomized, Double-Blind, Placebo-Controlled Study designed to as...
Location
Multiple Locations
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
PHASE2This is a Phase II, open-label study designed to To evaluate the safety and...
Location
Multiple Locations
Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
PHASE2This is a Phase II, open-label study designed to evaluate the safety, effic...
Location
Multiple Locations
Study of NM8074 in Patients with Dermatomyositis (DM)
PHASE2This is a Phase II, open-label, multicenter study to evaluate the safety an...
Location
Multiple Locations
First-in-Human (FIH) Clinical Study of NM8074 in Healthy Adult Volunteers
PHASE1This is a Phase 1 randomized, double-blind, placebo-controlled, single admi...
Location
Covance Clinical Unit
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
PHASE2This is a Phase II, open-label study designed to determine if intravenously...
Location
Multiple Locations